Home Journals Articles Updates About
CN
image
收藏切换
A sequential continuous flow synthesis and purification process of calcium dibutyryladenosine cyclophosphate
收藏切换
PDF
Liming Caoa, Maolin Sunb, *, Chaoming Liangb, Lei Yanga, Yueyue Mab, Ruihua Chengb, Yanxiong Kea, *, Wei Yua, c, Jinxing Yea, b, *
Chinese Chemical Letters | 2024, 35(2) : 108758
Less
收藏切换
Chinese Chemical Letters | 2024, 35(2): 108758
• Communication •
A sequential continuous flow synthesis and purification process of calcium dibutyryladenosine cyclophosphate
Full
Liming Caoa, Maolin Sunb, *, Chaoming Liangb, Lei Yanga, Yueyue Mab, Ruihua Chengb, Yanxiong Kea, *, Wei Yua, c, Jinxing Yea, b, *
Affiliations
  • a Engineering Research Center of Pharmaceutical Process Chemistry, Ministry of Education, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China
  • b School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China
  • c Shanghai No.1 Biochemical & Pharmaceutical Co., Ltd., Shanghai 200080, China
Published: 2024-02-15 doi: 10.1016/j.cclet.2023.108758
Outline
收藏切换

Calcium dibutyryladenosine cyclophosphate is a widely used cardiovascular drug. The traditional batch synthesis process suffers from long reaction times, tedious operations, and unstable yields. Herein, a sequential continuous flow synthesis combined with a multistage in-line purification process of calcium dibutyryladenosine cyclophosphate was developed. The acylation reaction was completed in a continuous coil reactor at 160 ℃ in 20 min. And the high toxic solvent pyridine was replaced by acetonitrile. Furthermore, the multistage in-line purification process was integrated into the homemade 3D circular cyclone-type micromixer chip. Combining with the membrane phase separators, the residence time of the purification step was 30 s. The isolated yield of this sequential continuous process was 92% with 99% purity.

Flow chemistry  /  Calcium dibutyryladenosine cyclophosphate  /  Continuous flow synthesis  /  In-line purification  /  3D circular cyclone-type micromixer chip
Liming Cao, Maolin Sun, Chaoming Liang, Lei Yang, Yueyue Ma, Ruihua Cheng, Yanxiong Ke, Wei Yu, Jinxing Ye. A sequential continuous flow synthesis and purification process of calcium dibutyryladenosine cyclophosphate[J]. Chinese Chemical Letters, 2024 , 35 (2) : 108758 - . DOI: 10.1016/j.cclet.2023.108758
Full Text
Less
Adenosine-3′, 5′-cyclic cyclophosphate (Scheme 1, cAMP, 1) is an essential intracellular second messenger controlling the critical cellular functions [1]. The introduction of lipophilic side chains in position N6 and/or 2′-O of cAMP enhances its membrane permeability and overcomes its defect to being easily destructed by cyclic nucleotide phosphodiesterase [2–4]. Calcium dibutyryladenosine cyclophosphate (or calcium N6, 2′-O-dibutyryl cyclic adenosine-3′, 5′-monophosphate. Scheme 1, dbcAMP-Ca, 2), derived from cAMP, is used in the clinical treatment of cardiovascular diseases, such as angina pectoris and acute myocardial infarction [5].
In 1960s, Posternak and co-workers developed a synthesis method for dbcAMP [6–8]. This method typically consisted of three steps, the synthesis of cAMP-Et3N, the acylation reaction, and the purification process (Scheme 2a). It was widely used in industrial production because of the mild conditions and clear reaction mechanism [9–12]. However, this process suffered from the long reaction time (4–10 days) and utilization of pyridine, which is an undesirable solvent in the pharmaceutical industry due to its high toxicity [13]. In addition, tedious extraction and washing were time-consuming and unstable in the purification process, as the prolonged treatment of dbcAMP in aqueous could lead to hydrolysis [9,14]. Therefore, an efficient, robust, and operationally convenient process for the synthesis of dbcAMP-Ca is greatly needed.
In recent years, continuous flow chemistry has become a research hotspot both in academia and industry [15–21]. Compared to the traditional batch synthesis, the continuous flow mode is more reliable and reproducible due to the accurate control of the reaction parameters, such as temperature, pressure, reagent dosage, and residence time [22]. It is also characterized by the fast heat and mass transfer rates, significantly improving the overall safety of the organic synthesis process even under harsh reaction conditions [23,24]. Besides, the scale-up continuous flow process could be achieved rapidly by changing the reactor volume with less process optimization [25,26]. So far, many new continuous flow processes for drug synthesis were developed in decades [27–29].
Herein, we described a sequential continuous flow synthesis and purification process for dbcAMP-Ca (Scheme 2b). By combining the continuous acylation reaction in a coil reactor with the multistage in-line purification based on femtosecond laser-tailored 3D circular cyclone-type micromixer chips, the limitations of long production cycles, large amounts of highly toxic reagents, and unstable yields in traditional batch processes was eliminated.
The presence of a tertiary amine was necessary for the acylation reaction [14], and cAMP-Et3N could be easily prepared. Thus cAMP-Et3N was prepared on a large scale as the starting material (see Supporting information for details of the synthesis procedure). Then, the conditions of the acylation reaction were screened in batch (Table S2 in Supporting information). DMAP (4-(N,N-dimethylamino)-pyridine), the effective nucleophilic base for the acylation of amine and alcohols [30,31], could significantly improve the reaction efficiency (Table S2, entry 3). Acetonitrile was used as solvent for the acylation reaction replacing pyridine (Table S2, entry 4 and Table S3 in Supporting information). When 20 equiv. of n-butyric anhydride and 1 mol% DMAP were added, the quantitative conversion was obtained on a 1 mmol scale at 100 ℃ for 3 h (Scheme 3).
In order to further enhance the acylation process, screening of the acylation conditions was carried out in continuous flow (Table 1). A 316L stainless steel coil was used as the flow reactor, with a gas chromatography oven and a back pressure regulator (BPR) to control the temperature and the pressure (Fig. S1 in Supporting information). It was worth noting that premixing cAMP-Et3N, n-butyric anhydride, and DMAP in acetonitrile into a clear solution was necessary to prevent clogging. In the presence of 0.5 mol% DMAP, the conversion was almost quantitative at 140 ℃ with a residence time of 25 min (entries 1 and 2). Increasing the temperature further accelerated the reaction and thus shorten the required residence time (entry 3). Reducing the amount of DMAP to 0.3 mol%, a high yield was obtained as well by increasing the temperature to 160 ℃ with 20 min (entries 4–7). Further reduction in the amount of DMAP to 0.1 mol% lead to reduced conversion (68%, entry 8). When the temperature was increased to 170 ℃, several impurities were generated and the yield decreased to 90% (entry 9). Moreover, a long run of the continuous acylation was carried out to demonstrate the process stability (entry 10). The flow process proceeded smoothly for 5 h with > 99% yield of 4 within the entire period (Table S4 in Supporting information).
In-line purification is an important tool to handle the unstable intermediates or multi-step sequential synthesis [32], and liquid–liquid continuous extraction is one of the common protocols [17,33–35]. Recently, we designed and fabricated a glass four-module micromixer chip with 3D circular cyclone-type channel using femtosecond laser micromachining (Fig. 1) [36–39]. Multiphase fluids could be fully mixed with high mass transfer efficiency in the millimeter-level 3D cyclone passive microchannel (Fig. 1a). This chip contains four individual modules, and separate temperature control channels were available for each module (Figs. 1b and c), allowing operations to be performed independently in each module. Compared to traditional single-module mixer, this chip has the advantages of being highly efficient, space-saving, and versatile.
Herein, we developed a multistage continuous purification process in the 3D four-module cyclone-type micromixer chip (Fig. S4 in Supporting information). As shown in Fig. 2, the acylation residue was hydrolyzed by H2O in Module Ⅰ, and the desired compound 4 could be extracted into the aqueous phase. MTBE (methyl t–butyl ether) was added to dilute the reaction mixture in Module Ⅰ to avoid blockage and facilitate phase separation (Table S5 in Supporting information for details). Zaiput membrane-based liquid–liquid separators (SEP-10) were used for phase separation. The adjustable BPRs were fitted at appropriate locations to ensure the differential pressure of less than 0.35 MPa at the outlets of the membrane separators [40]. Through Separator Ⅰ, the aqueous phase of Module Ⅰ flew directly into Module Ⅲ, and the organic phase of Module Ⅰ entered Module Ⅱ for the secondary extraction. After adding H2O by Pump D and separating by Separator Ⅱ, the aqueous phase of Module Ⅱ also flew into Module Ⅲ. The combined aqueous solution was acidified by 1 mol/L HCl (adjusted to pH 3–4), washed with extra MTBE to remove the resident fat-soluble impurities, such as n-butyric anhydride and n-butyric acid, and passed through Separator Ⅲ. The aqueous phase of Module Ⅲ was treated with CaHCO3 in batch, followed by concentration and recrystallization to obtain the desired dbcAMP-Ca (2). The second extraction in Module Ⅱ was necessary in this purification process as the yield could be improved effectively (Figs. S2 and S3, Tables S5-S7 in Supporting information). The isolated yield reached 92% (purity > 99%) with a chip throughput of 16.4 g/h. Compared to the batch processes, this continuous purification process significantly simplified operations and reduced the residence time to approximately 30 s, while increasing product yield and purity.
As shown in Fig. 3, the sequential continuous synthesis and purification process for dbcAMP-Ca was established. Firstly, the substrate solution was pumped into the coil reactor with a holding volume of 60 mL to achieve the full conversion from 3 to 4 at 160 ℃ in 20 min. Then the acylation output was directly pumped into the in-line purification setup containing a four-module cyclone mixer chip and three Zaiput membrane separators with the residence time of 30 s. Finally, the resulting aqueous solution was subjected to batch workup to provide the desired dbcAMP-Ca as a white solid.
In addition, we implemented a scale-up of the continuous purification process, for which the circular cyclone-type micromixer chips with wider channels were manufactured (Fig. S5 in Supporting information). The holding volume of each chip was 6.5 mL and the allowable flow rate was 0–100 mL/min. The isolated yield was maintained at 93% (purity 99%), the throughput was increased to 123 g/h, where the total flow residence time was prolonged to approximately 6 min.
In summary, we have developed a sequential continuous flow synthesis and purification process for dbcAMP-Ca. The quantitative conversion of the continuous flow acylation reaction was achieved in 20 min and the high toxic solvent pyridine was replaced by acetonitrile. In the industrial application, the continuous acylation could be further optimized by using a screw pump for solid delivery. The multistage in-line purification process based on femtosecond laser-tailored 3D circular cyclone-type micromixer chips simplified the operation and improved the process stability. The yield of dbcAMP-Ca was up to 92% (purity > 99%). Both the continuous acylation reactions and purification process could be expanded by increasing the reactor capacity. In addition, this multi-step continuous flow process overcomes the drawbacks of long reaction time, tedious operation, and unstable yields in the current synthesis process of dbcAMP-Ca and has the potential for further industrial development.
Declaration of competing interest
Less
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgments
Less
This work was partially supported by the National Natural Science Foundation of China (No. 22278087). We acknowledge Prof. Ya Cheng and Dr. Miao Wu for their contributions to the manufacture of the glass micromixer chips using femtosecond laser micromachining, and Prof. Xuhong Qian and Prof. Weiping Zhu for their insightful guidance and discussion during the entire research.
Supplementary materials
Less
Supplementary material associated with this article can be found, in the online version, at doi:10.1016/j.cclet.2023.108758.
References
Less
[1]
T. Hunter, Cell 100 (2000) 113–127.
[2]
W.F. Henion, E.W. Sutherland, T. Posternak, Biochim. Biophys. Acta 148 (1967) 106–113.
[3]
M.D. Plooy, G. Michal, G. Weimann, et al., Biochim. Biophys. Acta 230 (1971) 30–39.
[4]
T. Posternak, G. Weimann, Meth. Enzymol. 38 (1974) 399–409.
[5]
Y.D. Li, W.X. Li, Med. Recapitulate 23 (2017) 985–988.
[6]
R.W. Butcher, E.W. Sutherland, J. Bio. Chem. 237 (1962) 1244–1250.
[7]
J.G. Falbriard, T. Posternak, E.W. Sutherland, Biochim. Biophys. Acta 148 (1967) 99–105.
[8]
T. Posternak, E.W. Sutherland, W.F. Henion, Biochim. Biophys. Acta 65 (1962) 558–560.
[9]
S.Y. Choi, E.M. Chait, Patent, US2004186282, 2004.
[10]
Z. Huang, Z. Zhang, Patent, CN1554358, 2003.
[11]
J. Zhou, J. Xu, Patent, CN101020708, 2007.
[12]
W. Liu, Z. Zhang, Patent, CN105566424, 2016.
[13]
K. Alfonsi, J. Colberg, P.J. Dunn, et al., Green Chem. 10 (2008) 31–36.
[14]
N. Atsushi, S. Susumu, Patent, JPS59155400 A, 1984.
[15]
F. Lévesque, P.H. Seeberger, Angew. Chem. Int. Ed. 51 (2012) 1706–1709.
[16]
T. Tsubogo, H. Oyamada, S. Kobayashi, Nature 520 (2015) 329–332.
[17]
A. Adamo, R.L. Beingessner, M. Behnam, et al., Science 352 (2016) 61–67.
[18]
J. Xie, D. Zhao, Chin. Chem. Lett. 31 (2020) 2395–2400.
[19]
Y. Xin, S. Peng, J. Chen, et al., Chin. Chem. Lett. 31 (2020) 1448–1461.
[20]
W. Li, Y. Li, W. Zhang, et al., Chin. Chem. Lett. 32 (2021) 1131–1134.
[21]
J. Ren, M. Wu, K. Dong, et al., Chin. Chem. Lett. 34 (2023) 107694.
[22]
A. Domokos, B. Nagy, B. Szilágyi, et al., Org. Process Res. Dev. 25 (2021) 721–739.
[23]
B. Gutmann, D. Cantillo, C.O. Kappe, Angew. Chem. Int. Ed. 54 (2015) 6688–6728.
[24]
M. Movsisyan, E.I.P. Delbeke, J.K.E.T. Berton, et al., Chem. Soc. Rev. 45 (2016) 4892–4928.
[25]
J. Wegner, S. Ceylan, A. Kirschning, Adv. Synth. Catal. 354 (2012) 17–57.
[26]
R. Porta, M. Benaglia, A. Puglisi, Org. Process Res. Dev. 20 (2016) 2–25.
[27]
D.L. Hughes, Org. Process Res. Dev. 22 (2018) 13–20.
[28]
M. Sun, J. Yang, Y. Fu, et al., Org. Process Res. Dev. 25 (2021) 1160–1166.
[29]
C. Shan, L. Cao, J. Yang, et al., React. Chem. Eng. 7 (2022) 1779–1785.
[30]
W. Steglich, G. Höfle, Angew. Chem. Int. Ed. 8 (1969) 981-981.
[31]
G. Höfle, W. Steglich, H. Vorbrüggen, Angew. Chem. Int. Ed. 17 (1978) 569–583.
[32]
N. Weeranoppanant, A. Adamo, ACS Med. Chem. Lett. 11 (2020) 9–15.
[33]
H. Sprecher, M.N.P. Payán, M. Weber, et al., J. Flow Chem. 2 (2012) 20–23.
[34]
C. Dai, D.R. Snead, P. Zhang, J. Flow Chem. 5 (2015) 133–138.
[35]
J.C.M. Monbaliu, T. Stelzer, E. Revalor, et al., Org. Process Res. Dev. 20 (2016) 1347–1353.
[36]
J. Ye, R. Cheng, M. Sun, et al., Patent, CN115245801, 2022.
[37]
J. Ye, R. Cheng, M. Sun, et al., Patent, CN115245800, 2022.
[38]
M. Sun, C. Liang, L. Cao, et al., Chin. Chem. Lett. 35 (2024) 108738.
[39]
S. Hou, M. Sun, L. Cao, et al., Chin. Chem. Lett. (2023) 10.1016/j. cclet. 2023.108761.
[40]
P.L. Heider A. Adamo, N. Weeranoppanant, et al., Ind. Eng. Chem. Res. 52 (2013) 10802–10808.
Appendix
Less
Year 2024 volume 35 Issue 2
PDF
45
24
Cite this Article
BibTeX
Article Info
doi: 10.1016/j.cclet.2023.108758
  • Receive Date：2023-05-12
  • Online Date：2025-11-20
  • Published：2024-02-15
Article Data
Affiliations
History
  • Received：2023-05-12
  • Revised：2023-06-21
  • Accepted：2023-06-29
Affiliations
    a Engineering Research Center of Pharmaceutical Process Chemistry, Ministry of Education, School of Pharmacy, East China University of Science and Technology, Shanghai 200237, China
    b School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou 510006, China
    c Shanghai No.1 Biochemical & Pharmaceutical Co., Ltd., Shanghai 200080, China
References
Share
https://castjournals.cast.org.cn/joweb/ccl/EN/10.1016/j.cclet.2023.108758
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family		 属数
Number of
genus		 种数
Number of
species		 占总种数比例
Percentage of
total species (%)		 属
Genus		 种数
Number of
species		 占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT
Links
Articles
Latest Articles
Most Read
Collections
Updates
Events
News
Multimedia
About
About Us
Contact
No. 86 Xueyuan South Road, Haidian District, Beijing
100081
010-62199257
qkjq@cast.org.cn

Copyright © 2025 China Association for Science and Technology. All rights reserved. For all open access content, the relevant licensing terms apply.
Sponsored by the Office of the Leading Group for Cybersecurity and Informatization of CAST, and supported by Science and Technology Review Publishing House